effects [qlco]
Oral [spco]
Transdermal [ftcn]
Hormone replacement therapy [topp]
C-reactive protein level [lbpr]
Inflammatory [ftcn]
Marker [clna]
Women [popg]
High Risk [qlco]
Thrombosis [patf]
Introduction [hlca]
In [qnco]
Estrogen [horm, phsu, strd]
Venous Thromboembolism [patf]
Study [mnob]
Women [popg]
History [ocdi]
Venous Thromboembolism [patf]
Oral [spco]
Hormone replacement therapy [topp]
Strong [qlco]
Activation [acty]
Coagulation [ortf]
Marker [clna]
Increased [qnco]
Recurrent [tmco]
Venous Thromboembolism [patf]
Associations [menp]
Observed [ftcn]
Estrogen [horm, phsu, strd]
Women [popg]
Atherosclerosis [dsyn]
Study [mnob]
Women [popg]
Established [qlco]
coronary artery disease [dsyn]
GIVEN [cnce]
Transdermal [ftcn]
Hormone replacement therapy [topp]
objectives [inpr]
Methods [inpr]
Present [qnco]
Study [mnob]
Evaluate [ftcn]
effects [qlco]
Oral [spco]
Transdermal [ftcn]
Hormone replacement therapy [topp]
Levels [qlco]
C-reactive protein [aapp, imft]
Assay [lbpr]
Highly sensitive [qlco]
Evaluated [ftcn]
effects [qlco]
Inflammatory [ftcn]
Marker [clna]
influential [idcn]
Oral [spco]
Hormone replacement therapy [topp]
C-reactive protein [aapp, imft]
3 Months [tmco]
Compared [acty]
placebo [topp]
P NOS [aapp, imft]
Sustained [ftcn]
months [tmco]
Hormone replacement therapy [topp]
C-reactive protein [aapp, imft]
Women [popg]
Thrombosis, recurrent [fndg]
tnf alpha [aapp, imft]
Levels [qlco]
Decreased [qnco]
P NOS [aapp, imft]
soluble [celc]
VCAM-1 [aapp, imft]
Decreased [qnco]
Hormone replacement therapy [topp]
Group [idcn]
Compared [acty]
placebo [topp]
Group [idcn]
P NOS [aapp, imft]
Levels [qlco]
IL6 [aapp, imft]
TGF-beta [aapp, bacs]
P-Selectin [aapp, imft]
Transdermal [ftcn]
Hormone replacement therapy [topp]
C-reactive protein [aapp, imft]
Observed [ftcn]
months [tmco]
treatment [ftcn]
Conclusions [idcn]
findings [ftcn]
Oral [spco]
Hormone replacement therapy [topp]
Containing [ftcn]
Estradiol [horm, phsu, strd]
Marked [qlco]
Rapid [qlco]
Transdermal [ftcn]
treatment [ftcn]
Oral [spco]
treatment [ftcn]
increases [ftcn]
Inflammatory [ftcn]
Marker [clna]
Ireland [geoa]
LTD [ortf]
Reserve [acty]
